Neuraxial Anesthesia for Surgery
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify if you need to stop taking your current medications. However, if you are on anticoagulants, they may need to be held for a certain period based on guidelines.
What data supports the effectiveness of the treatment Neuraxial Anesthesia for surgery?
Is neuraxial anesthesia generally safe for humans?
Neuraxial anesthesia, which includes spinal and epidural anesthesia, is generally considered safe, but there are rare risks of serious complications like cardiac arrest, neurological damage, and infections. Most complications are uncommon, and the practice requires careful management to minimize risks.678910
How is neuraxial anesthesia different from other treatments for surgery?
Neuraxial anesthesia, which includes spinal and epidural anesthesia, is unique because it provides pain relief by blocking nerve signals in specific areas of the body, allowing for increased patient mobility and quicker recovery compared to general anesthesia. It is particularly beneficial for surgeries where targeted pain relief is needed without affecting the entire body.2341112
What is the purpose of this trial?
The ALOFT Pilot Trial will evaluate three pragmatic elements (recruitment, adherence, and follow-up) of neuraxial versus general anesthesia for lower limb revascularization surgery that are necessary to support a successful, large-scale evaluation. We will concurrently use implementation science methodology to further refine processes for the larger trial.The future full ALOFT trial will be designed to evaluate the comparative effectiveness of two different anesthesia types for improving outcomes.
Research Team
Daniel McIsaac, MD
Principal Investigator
The Ottawa Hospital
Eligibility Criteria
The ALOFT Pilot Trial is for adults over 18 who are scheduled for lower limb revascularization surgery, like arterial bypass or angioplasty. Participants need to be able to use a phone for follow-up. It's not specified who can't join the trial.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo lower limb revascularization surgery with either neuraxial or general anesthesia
Follow-up
Participants are monitored for safety and effectiveness after surgery, including assessments at 30 days, 90 days, and 1 year
Extension
Long-term follow-up to assess health-related quality of life and other outcomes
Treatment Details
Interventions
- Neuraxial Anesthesia
Neuraxial Anesthesia is already approved in European Union, United States, Canada, Japan for the following indications:
- Lower limb revascularization surgery
- Pain management
- Lower limb revascularization surgery
- Pain management
- Obstetric procedures
- Lower limb revascularization surgery
- Pain management
- Lower limb revascularization surgery
- Pain management
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ottawa Hospital Research Institute
Lead Sponsor
The Ottawa Hospital Academic Medical Association
Collaborator
Canadian Institutes of Health Research (CIHR)
Collaborator
University of Ottawa
Collaborator